Guy Broadbent is listed as an executive officer and director on 10 SEC Form D filings by 4 issuers between Feb 2011 and Aug 2020: CORVIUM, INC. (Reston, VA — industry reported as "Other" — 2013–2016; $13.5M reported sold to 6 investors), Thrive Bioscience, Inc. (Wakefield, MA — biotechnology — 2015–2017; $7.15M reported sold to 36 investors), Radical Plastics, Inc. (Beverly, MA — other technology — 2019–2020; $2.28M reported sold to 20 investors) and Xcellerex, Inc. (Marlborough, MA — industry reported as "Other" — 2011; $1.96M reported sold to 3 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $24.9M sold in total.
Listed alongside Michael Koeris (4 shared filings), Timothy Lu (4 shared filings), Alan Philippe Blanchard (3 shared filings), Brock Reeve (3 shared filings), Michael Finney (3 shared filings) and 20 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Guy. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for Guy Broadbent and found 6 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.